These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7585629)

  • 1. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
    Moscatello DK; Holgado-Madruga M; Godwin AK; Ramirez G; Gunn G; Zoltick PW; Biegel JA; Hayes RL; Wong AJ
    Cancer Res; 1995 Dec; 55(23):5536-9. PubMed ID: 7585629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
    Wikstrand CJ; Hale LP; Batra SK; Hill ML; Humphrey PA; Kurpad SN; McLendon RE; Moscatello D; Pegram CN; Reist CJ
    Cancer Res; 1995 Jul; 55(14):3140-8. PubMed ID: 7606735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.
    Lorimer IA; Wikstrand CJ; Batra SK; Bigner DD; Pastan I
    Clin Cancer Res; 1995 Aug; 1(8):859-64. PubMed ID: 9816055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
    Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the EGFR in fibroadenomas compared to breast carcinomas.
    Zelada-Hedman M; Werer G; Collins P; Bäckdahl M; Perez I; Franco S; Jimenez J; Cruz J; Torroella M; Nordenskjöld M
    Anticancer Res; 1994; 14(5A):1679-88. PubMed ID: 7847801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
    Lee H; Maihle NJ
    Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Olsen DA; Corydon T; Lorentzen KA; Knudsen HJ; Jeppesen U; Brandslund I; Jakobsen A
    Clin Cancer Res; 2008 Jun; 14(11):3278-82. PubMed ID: 18519753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
    J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a truncated epidermal growth factor receptor-like protein (TEGFR) in ovarian cancer.
    Ilekis JV; Gariti J; Niederberger C; Scoccia B
    Gynecol Oncol; 1997 Apr; 65(1):36-41. PubMed ID: 9103388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors.
    Moscatello DK; Ramirez G; Wong AJ
    Cancer Res; 1997 Apr; 57(8):1419-24. PubMed ID: 9108438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of c-jun oncogene expression in human breast using a new monoclonal antibody, NCL-DK4.
    Tiniakos DG; Scott LE; Corbett IP; Piggott NH; Horne CH
    J Pathol; 1994 Jan; 172(1):19-26. PubMed ID: 7931823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
    Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA
    Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
    J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.
    Hicks DG; Short SM; Prescott NL; Tarr SM; Coleman KA; Yoder BJ; Crowe JP; Choueiri TK; Dawson AE; Budd GT; Tubbs RR; Casey G; Weil RJ
    Am J Surg Pathol; 2006 Sep; 30(9):1097-104. PubMed ID: 16931954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor receptors as molecular targets for cancer diagnosis and therapy.
    Zalutsky MR
    Q J Nucl Med; 1997 Jun; 41(2):71-7. PubMed ID: 9203846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
    Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
    Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.